WEAV

Weave Communications Inc
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$529.11M
P/E Ratio
EPS
$-0.32
Beta
1.68
52W High
$8.11
52W Low
$4.24
50-Day MA
$6.03
200-Day MA
$6.04
Dividend Yield
Profit Margin
-10.10%
Forward P/E
PEG Ratio

About Weave Communications Inc

Weave Communications, Inc. provides a customer communication and interaction software platform in the United States and Canada. The company is headquartered in Lehi, Utah.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$248.72M
Gross Profit (TTM)$179.91M
EBITDA$-15.24M
Operating Margin-8.80%
Return on Equity-32.90%
Return on Assets-8.19%
Revenue/Share (TTM)$3.21
Book Value$1.05
Price-to-Book5.89
Price-to-Sales (TTM)2.13
EV/Revenue1.888
EV/EBITDA-54.51
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)17.40%
Shares Outstanding$79.57M
Float$63.86M
% Insiders8.91%
% Institutions86.35%

Historical Volatility

HV 10-Day
78.20%
HV 20-Day
64.74%
HV 30-Day
61.29%
HV 60-Day
67.86%
HV Rank
78.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($8.75 target)
2
Strong Buy
2
Buy

Latest News

Weave Launches Authorized Integration with Elation Health, Significantly Reducing Manual Workflows for Primary Care Practices

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced a new authorized integration with Elation Health, a leading clinical platform for independent primary care. The integration reduces manual work and improves operational efficiency by connecting patient communication directly to the practice's electronic health record (EHR). Independent and direct primary care practices often manag.

Business Wire7/17/2026Neutral
Weave Communications: Why Its Shift To Consumption Pricing Makes It A Buy Opportunity

Weave Communications earns a Strong Buy rating with a $9.60/share target, driven by a shift to hybrid, usage-based AI pricing. Q1 revenue grew 17.4% YoY to $65.5M, with gross margin rising to 73.2% and operating leverage improving as new revenue converts efficiently to profit. AI-driven solutions and the TrueLark acquisition address clinic labor shortages, increase ARPU, and position WEAV as a specialized healthcare SaaS outperformer.

Seeking Alpha7/13/2026Positive
Weave Earns Prestigious 2026 USA TODAY Top Workplaces Award

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, announced that it has earned the prestigious 2026 USA TODAY Top Workplaces award. “Earning this recognition directly from our own people is the highest form of validation. At Weave, culture isn't a destination but a commitment we renew every day, and investing in world-class talent is how we future-proof everything we build,” said Brooke Shreeve,.

Business Wire7/9/2026Neutral
Weave Ranks No. 1 in G2's Summer 2026 Patient Relationship Management Grid Report

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, has been named the No. 1 Leader in G2's Summer 2026 Grid® Report for Patient Relationship Management (PRM) software, earning the highest satisfaction score and largest market presence of any product in the category."Being named the No. 1 PRM platform in G2's Summer report reflects the trust our customers place in us every day," said Brett White, C.

Business Wire7/8/2026Neutral
KILN TO ANCHOR HOSPITALITY-DRIVEN FLEXIBLE WORKSPACE AND COMMUNITY HUB IN THE WEAVE AT OCVIBE

New Partnership Brings World-Class Coworking to OCVIBE, Reinforcing Anaheim's Evolution into a Dynamic Destination for Business, Culture, and Entertainment ANAHEIM, Calif., June 15, 2026 /PRNewswire/ -- OCVIBE, the 100-acre mixed-use district shaping the future of Anaheim, today announced that Kiln, the hospitality-driven coworking and flexible office operator known for creating elevated workplace communities across the Western U.S., has committed to a full floor at The Weave, OCVIBE's mass timber office building.

PRNewsWire6/15/2026Neutral
Weave Bio Enables Global Submissions From a Single Source of Truth

SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AI--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced new global submission capabilities that give drug development teams one connected platform for every regulatory filing across a program's lifecycle, from an Investigational New Drug (IND) application and Clinical Trial Application (CTA) to a New Drug Application (NDA) and beyond. Available immediately, the enhancements establish a single source of truth across jurisdict.

Business Wire6/15/2026Neutral
Weave Joins athenahealth's Marketplace Program, Giving Healthcare Practices Better Tools for Growth

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced an agreement with athenahealth, Inc. through the company's award-winning athenahealth® Marketplace program. The newly integrated application helps athenahealth's growing network of healthcare providers connect practice operations and patient engagement. The Weave and athenahealth integration addresses the most common revenue leaks.

Business Wire6/11/2026Neutral
Weave Announces First Quarter 2026 Financial Results

LEHI, Utah--(BUSINESS WIRE)--Weave Communications, Inc. (“Weave”) (NYSE: WEAV), a leading vertical SaaS platform that delivers AI-powered patient engagement and payment solutions for small and medium-sized healthcare practices, today announced its financial results for the first quarter ended March 31, 2026. "Weave delivered another excellent quarter, with revenue growth accelerating to 17.4% year-over-year and the most customer location additions in a single quarter in our history. We also dro.

Business Wire4/30/2026Neutral
Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle

SAN FRANCISCO & RALEIGH, N.C.--(BUSINESS WIRE)-- #Biotech--Weave Bio, the leader in AI-native regulatory automation for drug development, and strategic partner Parexel, a leading global clinical development partner, today announced that the Weave platform now supports New Drug Application (NDA) submissions, advancing the company's coverage of the full regulatory lifecycle. Parexel brings more than 40 years of regulatory experience and a track record of successful NDA submissions to the partnership. Throug.

Business Wire4/29/2026Neutral
Weave Call Intelligence Helps Address Rising Care Deferral as Patients Delay Procedures Over Concerns About Affordability

LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient communications and engagement platform purpose-built for healthcare practices, today announced a series of platform enhancements to one of its leading AI products, Call Intelligence. The latest updates turn the product from a robust analytics tool into a deeply embedded, AI-driven workflow engine for modern healthcare practices. The announcement comes at a pivotal moment for the healthcare industry. According to recen.

Business Wire4/22/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WEAV and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026